Back to search
Bioequivalence
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Bioequivalence trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Bioequivalence trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study will investigate the bioequivalence between two formulations of HRS-1893 tablets. Safety and tolerability will also be assessed.
This clinical study is testing two versions of the study medicine cagrilintide. The purpose of the study is to compare these two versions to understand their ef…
This study aims to compare the PK of Navlimetostat after administration of a wet-granulation tablet versus the dry-granulation tablet formulation in healthy adu…
The purpose of this study is to compare the single-dose pharmacokinetics (PK) of casdatifan 100 mg versus four 25 mg tablets under fasting conditions in healthy…
The primary objective of this trial is to assess bioequivalence of two formulations of survodutide (formulation A and formulation B6) after multiple-dose treatm…
To evaluate and compare the safety and pharmacokinetic profiles of "AJU-G721" (test drug) and "G721R" (reference drug) in healthy adult male subjects.
This study is a single-center, open-label, randomized, single-dose bioequivalence trial conducted in healthy adult participants.
The purpose of this clinical trial is to compare the amount of tafamidis in the blood of healthy adult participants after taking two different forms of tafamidi…